http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20060123541-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae84948901b77f34fd51c41264d8d19c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate 2005-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85d15740e6dd937e6e3dff40bca5fb7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf825d66414f34bd8a4a19afb53c0089
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_697c457f052c9fce2ca49f32e8cd6e7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e50574816e4bc2ae536d3ed1d2c60c7f
publicationDate 2006-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20060123541-A
titleOfInvention Neutral Endopeptidase (NEP) and Human Soluble Endopeptidase (hSEP) Inhibitors for the Prevention and Treatment of Neurodegenerative Diseases
abstract The present invention relates to known benzazine, benzoxazepine, benzothiazepine-N-acetic acid and phosphono-substituted with neutral endopeptidase (NEP) and / or human soluble endopeptidase (hSEP) inhibitory activity. A novel use of benzazepineone derivatives. The compounds of the present invention are useful for the preparation of pharmaceutical compositions for the prevention and treatment of neurodegenerative diseases. Compounds of the invention are known from EP 0 733 642 and EP 0 916 679 and can be represented by the formula (1).n n n Formula 1n n n n n n n n In Formula 1, the symbols are as defined in the present specification.
priorityDate 2004-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410117236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148200972

Total number of triples: 23.